BLUEFIN CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
BLUEFIN CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$234
-96.1%
46,7000.0%0.00%
-100.0%
Q3 2022$6,000
-87.2%
46,7000.0%0.00%
-80.0%
Q2 2022$47,000
-42.0%
46,7000.0%0.01%
-28.6%
Q1 2022$81,000
-78.7%
46,7000.0%0.01%
-74.1%
Q4 2021$381,000
-11.8%
46,700
-0.6%
0.03%
-37.2%
Q3 2021$432,000
+195.9%
47,000
-2.1%
0.04%
+377.8%
Q2 2021$146,00048,0000.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders